ATE293628T1 - Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel - Google Patents

Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel

Info

Publication number
ATE293628T1
ATE293628T1 AT00953480T AT00953480T ATE293628T1 AT E293628 T1 ATE293628 T1 AT E293628T1 AT 00953480 T AT00953480 T AT 00953480T AT 00953480 T AT00953480 T AT 00953480T AT E293628 T1 ATE293628 T1 AT E293628T1
Authority
AT
Austria
Prior art keywords
ring
denotes
substituted
group
optionally substituted
Prior art date
Application number
AT00953480T
Other languages
English (en)
Inventor
Shigenori Ohkawa
Tadatoshi Hashimoto
Tetsuya Tsukamoto
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE293628T1 publication Critical patent/ATE293628T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
AT00953480T 1999-08-20 2000-08-18 Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel ATE293628T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23471999 1999-08-20
PCT/JP2000/005524 WO2001014385A1 (en) 1999-08-20 2000-08-18 Dihydrobenzofuran derivatives, process for the preparation thereof and agents

Publications (1)

Publication Number Publication Date
ATE293628T1 true ATE293628T1 (de) 2005-05-15

Family

ID=16975313

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00953480T ATE293628T1 (de) 1999-08-20 2000-08-18 Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel

Country Status (7)

Country Link
US (1) US7008940B1 (de)
EP (1) EP1213290B1 (de)
AT (1) ATE293628T1 (de)
AU (1) AU6595000A (de)
CA (1) CA2382418A1 (de)
DE (1) DE60019619T2 (de)
WO (1) WO2001014385A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1614684T3 (da) 2003-04-14 2009-04-14 Nippon Soda Co Diaminderivat, produktionsproces og antioxidantlægemiddel
US7465815B2 (en) * 2003-06-26 2008-12-16 Takeda Pharmaceutical Company Limited Cannabinoid receptor modulator
EP1743902A4 (de) * 2004-03-31 2009-04-01 Kuraray Co Verfahren zur herstellung eines 5-alpha-prägnanderivats
EP1767540A4 (de) * 2004-03-31 2009-04-01 Kuraray Co Verfahren zur herstellung eines 5-alpha-prägnanderivats
EP2246326A1 (de) * 2009-05-02 2010-11-03 Bayer CropScience AG Verfahren zur Herstellung von Oxindolen und ortho-substituierten Anilinen und ihre Verwendung als Zwischenprodukte für Synthesen

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54163598A (en) 1978-06-13 1979-12-26 Daiichi Seiyaku Co Pyridoquinoline derivative
US5071875A (en) 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
FR2680366B1 (fr) 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FR2681862B1 (fr) 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
CA2134448A1 (en) 1992-05-01 1993-11-02 Yoshinori Kyotani Quinoline derivative or salt thereof and remedy for cardiac diseases containing the same
FR2713636B1 (fr) 1993-12-07 1996-01-05 Adir Nouveaux dérivés naphtaléniques, leur procédé de préparation, et les compositions pharmaceutiques qui les contiennent.
GB9326192D0 (en) 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9407919D0 (en) 1994-04-21 1994-06-15 Glaxo Group Ltd Chemical compounds
US5856124A (en) 1994-06-17 1999-01-05 The General Hospital Corporation DNA encoding high-affinity melatonin receptors
FR2725985B1 (fr) 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6071946A (en) 1994-10-21 2000-06-06 Adir Et Compagnie Tricyclic urea compounds
US5998461A (en) 1994-10-21 1999-12-07 Adir Et Compagnie Tricyclic amide compounds
US5661186A (en) 1995-02-24 1997-08-26 Bristol-Myers Squibb Co. Tetralinyl-and indanyl-ethylamides
PL188093B1 (pl) * 1996-03-08 2004-12-31 Takeda Chemical Industries Ltd Związek trójpierścieniowy, sposób jego wytwarzania i zastosowanie, kompozycja farmaceutyczna oraz związki pośrednie
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
TW416953B (en) 1996-09-25 2001-01-01 Takeda Chemical Industries Ltd Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use
DE60014936T2 (de) 1999-08-20 2005-10-13 Takeda Chemical Industries, Ltd. Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel

Also Published As

Publication number Publication date
DE60019619D1 (de) 2005-05-25
EP1213290A1 (de) 2002-06-12
EP1213290B1 (de) 2005-04-20
US7008940B1 (en) 2006-03-07
EP1213290A4 (de) 2002-09-04
AU6595000A (en) 2001-03-19
DE60019619T2 (de) 2006-03-02
WO2001014385A1 (en) 2001-03-01
CA2382418A1 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
DE69111029D1 (de) Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung.
ID17851A (id) Persenyawaan heterosiklis, produksi dan pemakaiannya
EA200000731A1 (ru) Альфа-аминоамидные производные, полезные в качестве анальгетических агентов
DE69929669D1 (de) Zyklische Amidderivate die Cathepsin K hemmen
PT733621E (pt) Novos derivados de imidazole e processo para a sua preparacao
EA199800794A1 (ru) Новые производные арилглициламида, способ их получения и фармацевтическая композиция, содержащая эти соединения
EP1471064A4 (de) Cumarinderivate, verfahren zu deren herstellung und deren verwendung
ATE211474T1 (de) Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente
EP0881220A4 (de) Diarylsultam-derivate
DK1034174T3 (da) Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer
ATE194982T1 (de) Benzoxazepin-derivate als cholinesterase- inhibitoren
TR200001239T2 (tr) Tiyazolidinediyon türevlerini hazırlama prosesi.
AT389108B (de) Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE293628T1 (de) Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel
ATE214059T1 (de) 4,6-di-t-butyl-2,3-dihydrobenzothiophene, die ldl oxidation hemmen
DE60014936D1 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
ATE304004T1 (de) Verfahren zur herstellung von 2-alkyl-3- aminothiophen derivate und 3-aminothiophen derivate
DE69425970D1 (de) Benzol-derivate, verwendbar für ischämische erkrankungen
KR910015537A (ko) 신규 1-아릴술포닐-2-피페리디논 유도체, 이의 제조방법, 제조용 중간체, 의약품으로서의 용도 및 이 화합물을 함유하는 조성물
EA200101170A1 (ru) Галоидпроизводные 9-деоксо-9а-аза-9а-гомоэритромицина а
ES2174077T3 (es) Derivados de hidroxilamina antiisquemicos y composiciones farmaceuticas.
ATE384717T1 (de) Stereoisomere indolderivate, verfahren zu ihrer herstellung und ihre verwendung
KR900001696A (ko) 궤양치료 활성을 갖는 1.4-디아제핀 유도체
ATE286058T1 (de) Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung
ATE170188T1 (de) 2'-desoxy-5-fluoruridin, pharmazeutisch anwendbare salze davon, verfahren zu ihrer herstellung und antitumormedikament

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties